COMMUNIQUÉS West-GlobeNewswire

Inhibikase Therapeutics Announces FDA Orphan Drug Designation Granted to IKT-001 for the Treatment of PAH
23/07/2026
WILMINGTON, Del., July 23, 2026 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing IKT-001 for Pulmonary Arterial Hypertension [...]
Curonix teams with AAOS to help address chronic pain with safer, patient-centered care solutions
23/07/2026
This support helps expand access to trusted clinical tools and patient resources designed to advance evidence-based pain management education POMPANO BEACH, Fla., July 23, 2026 (GLOBE NEWSWIRE) -- Curonix LLC, a leading [...]
Collegium to Report Second Quarter 2026 Financial Results on August 6, 2026
23/07/2026
STOUGHTON, Mass., July 23, 2026 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading biopharmaceutical company focused on improving the lives of people living with serious and often misunderstood [...]
PetMeds Announces Proposed Sale-Leaseback of Headquarters and Distribution Center Buildings for $37 Million
23/07/2026
DELRAY BEACH, Fla., July 23, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx (Nasdaq: PETS), today announced that it has entered into a definitive agreement for a sale- [...]
HCW Biologics Reaches Milestones for Its Proprietary Tetravalent Second-Generation T-Cell Engager Program On Track To Initiate Clinical Trials in First Half 2027
23/07/2026
Company requested Type B pre-IND meeting with U.S. FDA to discuss development and regulatory strategy for its investigational tetravalent T-cell engager, HCW11-018b HCW11-018b has demonstrated potential for treating [...]
Atsena Therapeutics Receives Orphan Designation from the European Medicines Agency (EMA) for ATSN-101 and ATSN-201
23/07/2026
Orphan designation provides market exclusivity and development benefits in the European Union as both programs advance in global pivotal clinical trials DURHAM, N.C., July 23, 2026 (GLOBE NEWSWIRE) -- Atsena [...]
YD Bio and EG BioMed Conclude Successful Exhibition at BIO Asia-Taiwan 2026, Highlighting Innovations in Ophthalmology, Oncology Diagnostics, and Clinical Services
23/07/2026
Taipei, Taiwan, July 23, 2026 (GLOBE NEWSWIRE) -- YD Bio Limited (“YD Bio” or the “Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic [...]
Autonomix Medical Secures New U.S. Patent Strengthening Next-Generation Precision Neuromodulation Platform
23/07/2026
Patent Broadens Intellectual Property Protecting Advanced Autonomic Nervous System Assessment Technologies Designed to Enhance Patient Selection, Treatment Precision and Future Clinical Applications THE WOODLANDS, TX, [...]
Revolver Brewing Becomes Revolver Beer and Spirits, Extending the Blood & Honey Brand into Whiskey, Gin and Vodka
23/07/2026
New spirits line brings the bold blood orange and honey profile of Revolver’s iconic Blood & Honey beer to Whiskey, Gin and Vodka launching exclusively in Texas BRECKENRIDGE, Colo., July 23, 2026 (GLOBE NEWSWIRE [...]
BioAdaptives Inc. Announces Operational Readiness and Completion of the Commercial Supply Chain for Upcoming Product Launches
23/07/2026
LAS VEGAS, July 23, 2026 (GLOBE NEWSWIRE) -- via IBN -- BioAdaptives, Inc. (OTC: BDPT), a developer of science-driven wellness products, today announces the successful completion of its commercial manufacturing and [...]
Ciprocopan (NXP100) Receives Marketing Approval in China for the Treatment of Patients with PNH Previously Untreated with Complement Inhibitors
23/07/2026
First global approval of a once-daily, orally administered, Complement Factor B inhibitor Approval based on robust efficacy and safety data from Haisco's broad completed clinical development program in PNH Ciprocopan [...]
Scancell and Neuphoria Therapeutics Announce Merger Agreement and Financing
23/07/2026
All-share transaction creating a combined company to operate as Scancell advancing a pipeline of targeted, off-the-shelf, active immunotherapies Combined company to be listed on Nasdaq, in addition to Scancell’s [...]
Teladoc Health introduces a virtual care practice built around the person, shaping a new era of connected care
23/07/2026
Teladoc One is a model of care delivered as a single, predictive and adaptive experience to drive better health outcomes and address the rising total cost of care Multidisciplinary care teams, paired with always-on AI [...]
Serina Therapeutics Announces Completion of Enrollment and Dosing in Cohort 1 of Registrational Trial of SER-252 for Advanced Parkinson’s Disease
23/07/2026
- All eight patients enrolled and dosed in Cohort 1 ahead of previously disclosed guidance of the end of the third quarter of 2026 - - Independent Safety Monitoring Committee to review Cohort 1 safety and tolerability [...]
Correction: Choosing a Shaker Bottle for Thick Pre-Workout Powders: What Actually Prevents Clumping
23/07/2026
PROMIXX set out to fix what defined the manual shaker category, replacing the wire mixing ball with the Snap-Fit Agitator: a lid-locked mixing grid Cardiff, July 23, 2026 (GLOBE NEWSWIRE) -- The Snap-Fit Agitator is an [...]
Healthcare Holding Switzerland Secures CHF 80 Million Syndicated Financing
23/07/2026
Healthcare Holding Schweiz AG, a leading Swiss service provider and distributor of medical technology, has successfully closed a CHF 80 million syndicated financing. Healthcare Holding Schweiz is managed by Winterberg [...]
NMD Pharma Announces Publication Identifying Neuromuscular Junction Transmission Failure as a Novel Contributor to Age-Related Muscle Weakness
23/07/2026
New publication identifies neuromuscular junction transmission failure as a novel mechanism contributing to sarcopenia, with preclinical studies showing that ClC-1 inhibition improves neuromuscular transmission and [...]
VERAXA Biotech Appoints Christoph Erkel as Chief Scientific Officer to Advance BiTAC® Technology Platforms and Portfolio
23/07/2026
ZURICH, SWITZERLAND, July 23, 2026 (GLOBE NEWSWIRE) -- VERAXA Biotech AG (NASDAQ: VRXA; “VERAXA”), an emerging leader in designing novel cancer therapies, today announced the appointment of Christoph Erkel, Ph.D., as [...]
Commure Wins Two Stevie® Awards for Technology Excellence, Including Gold for Company of the Year in Healthcare Technology
23/07/2026
CEO Tanay Tandon honored as Executive of the Year MOUNTAIN VIEW, Calif., July 23, 2026 (GLOBE NEWSWIRE) -- Commure , the leading AI-native healthcare RCM & Ambient platform, today announced it has been recognized [...]

Pages